VIAGE THERAPEUTICS
Viage Therapeutics, a neuroscience company based on a platform of novel neurotherapeutics, was founded in 2018. The company is based on the ground-breaking research.
VIAGE THERAPEUTICS
Social Links:
Industry:
Biotechnology Clinical Trials Medical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.viagetx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt Global Site Tag Google Analytics 4
Investors List
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Seed Round - Viage Therapeutics
ANRI
ANRI investment in Seed Round - Viage Therapeutics
Zhongze
Zhongze investment in Seed Round - Viage Therapeutics
Remiges Ventures
Remiges Ventures investment in Seed Round - Viage Therapeutics
Miyako Capital
Miyako Capital investment in Seed Round - Viage Therapeutics
Official Site Inspections
http://www.viagetx.com Semrush global rank: 9.06 M Semrush visits lastest month: 445
- Host name: hue.pl3.dev
- IP address: 144.202.82.253
- Location: Seattle United States
- Latitude: 47.6144
- Longitude: -122.3447
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98121
More informations about "Viage Therapeutics"
Viage Therapeutics
Digestome’s pipeline includes SAR-optimized drug candidates with potential in depression, anxiety, inflammatory disease, tinnitus, and others. The drug candidates are gut-acting and gut-restricted, which suggests an advantageous …See details»
Viage Therapeutics - Crunchbase Company Profile
Organization. Viage Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contact Email …See details»
Viage - Remiges Ventures
Jun 1, 2021 https://viagetx.com; Viage Therapeutics was established by Remiges Ventures, based on the ground-breaking research of Dr. Kousaku Ohinata from Kyoto University. Food affects mood, so Dr. Ohinata was …See details»
Viage Therapeutics, Inc. | LinkedIn
Viage Therapeutics, Inc. | 204 followers on LinkedIn. Stimulate the mind, act in the gut. | Viage Therapeutics, a neuroscience company based on a platform of novel neurotherapeutics, was …See details»
Viage Therapeutics (fka Digestome Therapeutics) | VentureRadar
Viage Therapeutics, a neuroscience company based on a platform of novel neurotherapeutics, was founded in 2018. The company is based on the... ... Find out more about ...See details»
Viage Therapeutics (fka Digestome Therapeutics) | VentureRadar
Website: https://viagetx.com/ Develops novel neurotherapeutics targeting the gut-brain axis, aiming to treat cognitive impairment, depression, anxiety, and ...See details»
Viage Therapeutics - PitchBook
Viage Therapeutics General Information Description. Operator of a biotechnology company intended to develop drugs to treat psychiatric and inflammatory diseases. The company is …See details»
Viage Therapeutics, - Products, Competitors, Financials, Employees ...
CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve …See details»
Viage Therapeutics announces data from a Phase 1 study with
Viage Therapeutics announces data from a Phase 1 study with ... - BioSpaceSee details»
Viage Therapeutics
Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate mind via the gut-brain-axis, announced today the completion of a $10M Seed financing to …See details»
Viage Therapeutics announces data from a Phase 1 study with
Jul 26, 2023 - DGX-001 demonstrates changes in brain activity as measured by quantitative electroencephalography (qEEG), supporting a mechanism of action based on AVPR1A …See details»
Viage Therapeutics - 药物管线_专利_临床试验_投融营收
了解Viage Therapeutics (Viage Therapeutics)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 3篇新闻，疾病领域:神经系统疾病，内分泌与代谢疾病，技术平台:合成多肽，药 …See details»
Viage Therapeutics
Viage Therapeutics (Viage), a neuroscience company based on a platform of novel neurotherapeutics, today announced positive findings from its Phase 1 study of DGX-001, a …See details»
A to Z Index of Organizations - Canada.ca
Office of the Auditor General of Canada; Office of the Chief Electoral Officer; Office of the Commissioner for Federal Judicial Affairs Canada; Office of the Commissioner of Canada …See details»
Viage Therapeutics
Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate the central nervous system (CNS) via the gut-brain-axis, announced that the first patient has …See details»
Viagex région Genève et Pays de Gex
VIAGEX.COM 11/12/2024 Suivez mon groupe sur . Sortir , Age nda Gen ève. 11/12/2024: Sortir, Agenda Pays de Gex: 11/12/2024: Jardinage mois de decembreSee details»
Via Benefits |Sign In
Please wait while we load your dataSee details»
Viage Therapeutics announces data from a Phase 1 study with …
Jul 26, 2023 [email protected] . Author: Microsoft Office User Created Date: 7/27/2023 4:33:24 PM ...See details»
YGOrganization | Yu-Gi-Oh! news that ends misinformation
3 days ago YGOrganization is the world’s most reliable information source for all Yu-Gi-Oh! news and content.See details»
Viage Therapeutics
Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate the central nervous system (CNS) via the gut-brain-axis, announced today the completion of …See details»